Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Editing Approaches to Treat Alpha-1 Antitrypsin Deficiency.
Erion DM, Liu LY, Brown CR, Rennard S, Farah H. Erion DM, et al. Among authors: farah h. Chest. 2024 Oct 12:S0012-3692(24)05302-9. doi: 10.1016/j.chest.2024.09.038. Online ahead of print. Chest. 2024. PMID: 39401571 Free article. Review.
Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study.
Goedeker NL, Rogers A, Fisher M, Arya K, Brandsema JF, Farah H, Farrar MA, Felker MV, Gibbons M, Hamid OA, Harmelink M, Herbert K, Kichula E, King K, Lakhotia A, Lee BH, Kuntz NL, Parsons J, Rehborg R, Veerapaniyan A, Zaidman CM. Goedeker NL, et al. Among authors: farah h. Muscle Nerve. 2024 Dec;70(6):1247-1256. doi: 10.1002/mus.28267. Epub 2024 Oct 6. Muscle Nerve. 2024. PMID: 39370660
Israeli neonatal herpes simplex infection: Unique epidemiology and clinical profile.
Lagziel TG, Jurkowicz M, Gordon O, Mor M, Megged O, Nasrallah E, Jacob R, Melamed R, Blustein SL, Tasher D, Guri A, Regev A, Linder I, Brosh-Nissimov T, Bamberger E, Lavy RG, Lipman-Arens S, Shehadeh S, Farah H, Stein M. Lagziel TG, et al. Among authors: farah h. J Med Virol. 2024 Sep;96(9):e29934. doi: 10.1002/jmv.29934. J Med Virol. 2024. PMID: 39311627
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
96 results